Joyo Pharma
Guangzhou
About Joyo Pharma
Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $60.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Jun 2023)
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/joyo-pharma-36633 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.